These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 21326156)
1. Adjuvant therapy for stage II and III colon cancer. Meyerhardt JA Clin Adv Hematol Oncol; 2010 Nov; 8(11):772-4. PubMed ID: 21326156 [No Abstract] [Full Text] [Related]
2. Adjuvant therapy in stage II colon cancer: current approaches. Baddi L; Benson A Oncologist; 2005 May; 10(5):325-31. PubMed ID: 15851790 [No Abstract] [Full Text] [Related]
3. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089 [TBL] [Abstract][Full Text] [Related]
4. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers. Phelip JM; Molinié F; Delafosse P; Launoy G; Trétarre B; Bara S; Buémi A; Velten M; Danzon A; Ganry O; Bouvier AM; Grosclaude P; Faivre J Gastroenterol Clin Biol; 2010 Feb; 34(2):144-9. PubMed ID: 20079591 [TBL] [Abstract][Full Text] [Related]
5. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM; Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829 [TBL] [Abstract][Full Text] [Related]
15. Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC). Hamaguchi T; Shirao K; Moriya Y; Yoshida S; Kodaira S; Ohashi Y; Cancer Chemother Pharmacol; 2011 Mar; 67(3):587-96. PubMed ID: 20490797 [TBL] [Abstract][Full Text] [Related]
16. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set. O'Connell MJ; Campbell ME; Goldberg RM; Grothey A; Seitz JF; Benedetti JK; André T; Haller DG; Sargent DJ J Clin Oncol; 2008 May; 26(14):2336-41. PubMed ID: 18467725 [TBL] [Abstract][Full Text] [Related]
17. Re: Pooled analysis of fluorouracil-based adjuvant therapy of stage II and III colon cancer: who benefits and by how much? Elsaleh H; Iacopetta B J Clin Oncol; 2005 Jan; 23(3):653-4; author reply 654-5. PubMed ID: 15659520 [No Abstract] [Full Text] [Related]
18. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Taal BG; Van Tinteren H; Zoetmulder FA; Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for stage II (Dukes' B) colon cancer: too early for routine use. Wein A; Hahn EG; Merkel S; Hohenberger W Eur J Surg Oncol; 2000 Dec; 26(8):730-2. PubMed ID: 11087635 [No Abstract] [Full Text] [Related]
20. Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer. Gibbs P; Handolias D; McLaughlin S; Chapman M; Johns J; Faragher I Intern Med J; 2008 Apr; 38(4):265-9. PubMed ID: 18298558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]